期刊文献+

CD44和Fas在人乳腺癌中的表达及其相互关系 被引量:2

Expression of CD44 and Fas in human breast cancer and their relationship
下载PDF
导出
摘要 目的:通过观察人乳腺癌组织中CD44和凋亡调节蛋白Fas的表达,探讨CD44和Fas与乳腺癌的发生、转移和免疫逃逸的关系。方法:收集手术切除的人乳腺癌组织和癌旁相对正常乳腺组织,对36例乳腺癌标本进行检测。结果:CD44在相对正常乳腺组织中的表达率为2.8%,在有淋巴结转移和无淋巴结转移的阳性表达率分别为88.2%和42.1%,差异有统计学意义;Fas在相对正常乳腺组织中的表达率77.8%,在有淋巴结转移和无淋巴结转移的阳性表达率分别为58.9%和31.6%,差异有统计学意义;CD44与Fas之间存在相关关系。结论:CD44、Fas在乳腺癌的发生、转移和免疫逃逸方面可能起着重要的协同作用,为临床开展乳腺癌的生物治疗提供实验依据。 Objective: To investigate the expression of CD44 and Fas in human breast cancer tissues and to discuss the relationship between CD44 and Fas and the occurring, metastasis and immune escape of breast cancer. Methods: The human operation breast cancer tissues and relatively normal breast tissues were collected from surgical operation and the samples of 36 patients with breast cancer were analyzed by immunohistochemistry and computer imaging techniques. Results: The expression rate of CD44 in normal breast tissues was 2.8%, while in lymphnode metastasis group and nonlymphnode metastasis group it was 88. 2% and 42.1% respectively. The positive expression rate of Fas was 77.8% in normal breast tissues. The expression of Fas in lymphnode metastasis group and nonlymphnode metastasis group were 58.9% and 31.6% respectively. There was a linear correlation between the expression of CD44 and Fas. Conclusion: CD44 and Fas play an important role in the occurring, metastasis and immune escape of breast cancer. They must be very useful for the further clinical biological therapy of breast cancer.
出处 《解剖学杂志》 CAS CSCD 北大核心 2016年第1期35-38,共4页 Chinese Journal of Anatomy
基金 广东省科技计划项目(2012B031800311)
关键词 乳腺癌 CD44 凋亡调节蛋白 免疫组织化学 breast cancer CD44 apoptosis regulatory protein immunohistochemistry human
  • 相关文献

参考文献3

二级参考文献21

  • 1付英杰.人CD44的结构与功能[J].基础医学与临床,2006,26(6):657-661. 被引量:6
  • 2米贤军,杨接辉,李政,钟守军,段立锋,杨枚.乳腺癌组织蛋白酶D、c-erbB-2、P53、P16、nm23蛋白表达与淋巴结转移的关系[J].实用医学杂志,2007,23(14):2150-2152. 被引量:8
  • 3[1]Naot D,Sionov RV,Ish Shalom D. CD44:structure,function,and assiociation with the malignant process [J]. Adv Cancer Res,1997,71:241- 319.
  • 4[2]Herrera Gayol A,Jothy S. Adhesion protein in the biology of breast cancer: contribution of CD44 [J]. Exp Mol Pathol,1999,66(2):149- 156.
  • 5[3]Kaufmann M,Heider KH,Sinn HP,et al. CD44 variant exon epitpes in primary breast cancer and length of survival [J]. Lancet,1995,345(8950):615- 619.
  • 6[4]Dall P,Herider KH,Sinn HP,et al. Comparison of immunohistochemistry and RT PCR for detection of CD44v expression,a new prognostic factor in human breast cancer [J]. Int J Cancer,1995,60(4):471- 477.
  • 7[5]Rosen PP,Oberman HA. Tumors of the Mammary Gland [M]. Washington D.C: Armed Forces Institute of Pathology,1992,72- 76.
  • 8[6]Papotti M,Eusebi V,Gugliotta P,et al. Immunohistochemical analysis of benign and malignant papillary lesions of the breast [J]. Am J Surg Pathol,1983,7(5):451- 461.
  • 9[7]Mackay CR,Terpe HJ,Stauder R,et al. Expression and modulation of CD44 variant isoforms in humans [J]. J Cell Biol,1994,124(1- 2):71- 82.
  • 10[8]Mastsumura Y,Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation [J]. Lancet,1992,340(8827):1053- 1058.

共引文献31

同被引文献18

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部